Government

WHITE PAPERS AND CASE STUDIES

• How Utilities Can Thrive In The New Generative AI Reality

  This white paper explores the transformative potential of generative AI (gen AI) in the water utility sector, demonstrating how it can enhance efficiency, productivity, and decision-making across organizations of all sizes.

• Building A High-Quality IND From Scratch With Strategic Gap Analysis

  A biotech sponsor lacking in-house regulatory expertise engaged a partner to obtain strategic regulatory review, medical writing, project management, and electronic publishing (eCTD).

• Clinical Trial Starts Rose At Slower Pace In 2024

  Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.

• Boosting CMC Regulatory Efficiency In Gene Therapy

  Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.

• Optimize Your Oncology Trial Protocol With Real-World Data

  Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on.

• The Evolution Of Clinical Operations And The Growth Of FSP Partnerships

  Explore the integration of new technologies, the FSP’s role in promoting patient diversity, and how clinical operations leaders are increasingly becoming thought leaders within the industry.

• Achieving Licensing For A Healthcare Solution

  Facing strict regulations and tricky powders, a healthcare client sought an advanced filling solution. Learn how an expert collaboration led to licensed product, boosting precision and productivity.

• How Sponsors Can Leverage New Technologies To Lower Trial Costs

  This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.

• Does Asset Health Monitoring Have A Role In The Water Sector?

  See why collaboration with trusted vendors is crucial for deploying reliable, adaptable, and sustainable asset health solutions in the evolving water sector.

• Trial Rescue: Leadership Approach To Propel Clinical Development

  Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.

• Streamlining The Importing & Exporting Of Biological Samples

  Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.

• DEYAK Water Utility Drives Technology Advancement For Water Systems In Greece

  As part of Greece’s post-pandemic National Recovery and Resilience Plan, the government is prioritizing sustainable water and waste management alongside energy reform and digital modernization.